Ensysce Biosciences, Inc.
ENSC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001716947
In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Ensysce Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 20 | 1 | 14 | −5 |
| SharesConverted for a 1-for-20 split | 189.2K | 5 | 184.8K | −4.40K (−2.3%) |
| Value | $810.7K | $0 | $138.2K | −$672.5K (−83.0%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Ensysce Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 42,277 | $31.7K | 0.00% |
| Two Sigma Investments, LP | 39,870 | $29.9K | 0.00% |
| Acadian Asset Management LLC | 26,602 | $19.0K | 0.00% |
| Susquehanna International Group, LLP | 17,649 | $13.2K | 0.00% |
| Millennium Management LLC | 14,438 | $11.0K | 0.00% |
| Bank of America Corp | 6,051 | $4.54K | 0.00% |
| Plante Moran Financial Advisors, LLC | 248 | $186 | 0.00% |
Sold out (12)
Institutions that held Ensysce Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| HG Vora Capital Management, LLC | 2,462,500 | $529.0K |
| Vanguard Group Inc | 315,828 | $68.0K |
| Cerity Partners LLC | 150,000 | $32.0K |
| Geode Capital Management, LLC | 130,523 | $28.0K |
| Northern Trust Corp | 51,089 | $11.0K |
| Virtu Financial LLC | 41,789 | $9.00K |
| State Street Corp | 35,551 | $8.00K |
| Two Sigma Securities, LLC | 33,994 | $7.00K |
| Jane Street Group, LLC | 20,431 | $4.00K |
| StoneX Group Inc. | 12,781 | $2.75K |
| FNY Investment Advisers, LLC | 20 | $0 |
| Moneta Group Investment Advisors LLC | 5,116 | – |
Not filed for Q4 2022 yet (1)
Institutions that held Ensysce Biosciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Covington Capital Management | 100 | $0 |